OSE Pharma SA (OSE) — Tangible Net Worth Ratio
OSE Pharma SA (OSE) has a Tangible Net Worth Ratio of 15.3% as of June 2025. This metric is calculated by deducting intangible assets (€42.84 Million) from net assets (€50.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net assets of OSE Pharma SA for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
OSE Pharma SA Tangible Net Worth Ratio (2015–2024)
This chart shows how OSE Pharma SA's Tangible Net Worth Ratio has changed across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at 15.3%, reflecting net assets of €50.60 Million with intangible assets of €42.84 Million EUR. Also explore OSE net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for OSE Pharma SA (2015–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for OSE Pharma SA from 2015 to 2024, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see OSE market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 31.0% | €63.81 Million | €44.01 Million | €123.96 Million | ▲ +133.0 pp |
| 2023 | -102.0% | €22.98 Million | €46.40 Million | €82.05 Million | ▼ -52.1 pp |
| 2022 | -49.9% | €32.55 Million | €48.78 Million | €91.67 Million | ▼ -42.3 pp |
| 2021 | -7.5% | €47.53 Million | €51.12 Million | €101.52 Million | ▼ -21.7 pp |
| 2020 | 14.1% | €61.24 Million | €52.60 Million | €96.85 Million | ▲ +4.0 pp |
| 2019 | 10.1% | €58.49 Million | €52.60 Million | €88.89 Million | ▼ -4.7 pp |
| 2018 | 14.8% | €61.75 Million | €52.60 Million | €76.90 Million | ▲ +9.7 pp |
| 2017 | 5.1% | €55.45 Million | €52.60 Million | €77.35 Million | ▼ -13.3 pp |
| 2016 | 18.5% | €64.53 Million | €52.60 Million | €89.55 Million | ▼ -81.5 pp |
| 2015 | 100.0% | €14.48 Million | €0.00 | €17.00 Million | — |